BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7541603)

  • 1. High grade malignant lymphoma with clinical characteristics and immunophenotype of natural killer cells.
    Schleiffenbaum B; Rüegg R; Zimmermann D; Fehr J
    Am J Hematol; 1995 Jul; 49(3):221-31. PubMed ID: 7541603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytosis of large granular lymphocytes in patients with Hodgkin's disease.
    Kingreen D; Dalal BI; Heyman M; Phillips GL; Horsman D; Kidd P; Loughran TP
    Am J Hematol; 1995 Dec; 50(4):234-6. PubMed ID: 7485096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphatic leukemias of T and NK cell type.
    Kingreen D; Siegert W
    Leukemia; 1997 Apr; 11 Suppl 2():S46-9. PubMed ID: 9178839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
    Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
    Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
    Drénou B; Lamy T; Amiot L; Fardel O; Caulet-Maugendre S; Sasportes M; Diebold J; Le Prisé PY; Fauchet R
    Blood; 1997 Apr; 89(8):2966-74. PubMed ID: 9108417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
    Kato N; Yasukawa K; Onozuka T; Kikuta H
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteropathy-type T-cell lymphoma expressing NK-cell intraepithelial lymphocyte (NK-IEL) phenotype.
    Inagaki N; Asaoka D; Mori KL; Sohda N; Miura I; Miwa H; Sato N; Oshimi K
    Leuk Lymphoma; 2004 Jul; 45(7):1471-4. PubMed ID: 15359651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large granular lymphocyte proliferation with the natural killer-cell phenotype.
    Chan WC; Gu LB; Masih A; Nicholson J; Vogler WR; Yu G; Nasr S
    Am J Clin Pathol; 1992 Mar; 97(3):353-8. PubMed ID: 1543158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NK-cell lymphomas and NK-like T-cell lymphomas].
    Oshimi K
    Nihon Rinsho; 2000 Mar; 58(3):646-9. PubMed ID: 10741139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer T-cell lymphoma of the tongue.
    Cho KJ; Cho SG; Lee DH
    Ann Otol Rhinol Laryngol; 2005 Jan; 114(1 Pt 1):55-7. PubMed ID: 15697163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia.
    Gentile TC; Uner AH; Hutchison RE; Wright J; Ben-Ezra J; Russell EC; Loughran TP
    Blood; 1994 Oct; 84(7):2315-21. PubMed ID: 7522625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma.
    Drexler HG; Matsuo Y
    Leukemia; 2000 May; 14(5):777-82. PubMed ID: 10803505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
    Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aggressive extranodal NK-cell lymphoma arising from indolent NK-cell lymphoproliferative disorder.
    Huang Q; Chang KL; Gaal KK; Weiss LM
    Am J Surg Pathol; 2005 Nov; 29(11):1540-3. PubMed ID: 16224224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
    Ogura M; Ishida T; Tsukasaki K; Takahashi T; Utsunomiya A
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):199-207. PubMed ID: 27289375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
    Alvarez-Larrán A; Villamor N; Hernández-Boluda JC; Ferrer A; Camós M; Campo E; López-Guillermo A
    Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reversed C.P.C.: Aggressive NK-cell leukemia/lymphoma].
    Koyama T
    Rinsho Byori; 2001 Mar; Suppl 115():140-3. PubMed ID: 11391932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias.
    Cheung MM; Chan JK; Wong KF
    Semin Hematol; 2003 Jul; 40(3):221-32. PubMed ID: 12876671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer-cell lymphoma involving the gynecologic tract.
    Mhawech P; Medeiros LJ; Bueso-Ramos C; Coffey DM; Gei AF; Shahab I
    Arch Pathol Lab Med; 2000 Oct; 124(10):1510-3. PubMed ID: 11035585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.